XOSE ANTON
SUAREZ PUENTE
Catedrático de Universidad
Hospital Clinic Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (26)
2022
-
ATM germline variants in a young adult with chronic lymphocytic leukemia: 8 years of genomic evolution
Blood Cancer Journal
-
Correction: ATM germline variants in a young adult with chronic lymphocytic leukemia: 8 years of genomic evolution (Blood Cancer Journal, (2022), 12, 6, (90), 10.1038/s41408-022-00686-6)
Blood Cancer Journal
-
Detection of early seeding of Richter transformation in chronic lymphocytic leukemia
Nature Medicine, Vol. 28, Núm. 8, pp. 1662-1671
-
Molecular map of chronic lymphocytic leukemia and its impact on outcome
Nature Genetics, Vol. 54, Núm. 11, pp. 1664-1674
2021
-
IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics
Blood, Vol. 137, Núm. 21, pp. 2935-2946
2020
-
Cryptic insertions of the immunoglobulin light chain enhancer region near CCND1 in t(11;14)-negative mantle cell lymphoma
Haematologica
-
Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes
Blood, Vol. 136, Núm. 12, pp. 1419-1432
-
IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms
Nature Communications, Vol. 11, Núm. 1
-
Minimal spatial heterogeneity in chronic lymphocytic leukemia at diagnosis
Leukemia, Vol. 34, Núm. 7, pp. 1929-1933
-
The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome
Nature Cancer, Vol. 1, Núm. 11, pp. 1066-1081
2019
-
CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D12 mantle cell lymphoma
Blood, Vol. 133, Núm. 9, pp. 940-951
-
Chromosome 12p amplification in triple-negative/BRCA1-mutated breast cancer associates with emergence of docetaxel resistance and carboplatin sensitivity
Cancer Research, Vol. 79, Núm. 16, pp. 4258-4270
-
Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics
Nature Communications, Vol. 10, Núm. 1
-
Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia
Haematologica, Vol. 104, Núm. 3, pp. 576-586
-
The U1 spliceosomal RNA is recurrently mutated in multiple cancers
Nature, Vol. 574, Núm. 7780, pp. 712-716
2018
-
Chronic lymphocytic leukemia and mantle cell lymphoma: Crossroads of genetic and microenvironment interactions
Blood, Vol. 131, Núm. 21, pp. 2283-2296
-
Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia
Leukemia, Vol. 32, Núm. 3, pp. 645-653
-
The mutational landscape of small lymphocytic lymphoma compared to non-early stage chronic lymphocytic leukemia
Leukemia and Lymphoma, Vol. 59, Núm. 10, pp. 2318-2326
-
The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia
Nature Medicine, Vol. 24, Núm. 6, pp. 868-880